-
Bharat Biotech vaccine price: Covaxin now at Rs 400 for state governments
As per the statement issued by Bharat Biotech, they have reduced the price to Rs. 400 for state governments after recognizing the enormous challenges
-
Delhi covid-19 cases raised by 44,350 as per revised govt data
The revised cumulative coronavirus data of Delhi released by the state government, on Thursday morning has raised the case tally by 44,350 and fatalit
-
Covid-19 Vaccination: India crosses 15-crore vaccination mark
As per the report issued by the ministry, a total of 15,00,20,648 vaccine doses have been administered through 22,07,065 sessions.
-
Covishield: Serum Institute of India slashes price for states from Rs 400 to Rs 300 per dose
Adar Poonawalla in a tweet said that the company has taken a philanthropic decision to reduce the price of Covishield for states to Rs 300 dose effect
-
Over one crore covid-19 vaccine doses available with states, UTs: Govt
The central government has so far provided 15,95,96,140 vaccine doses to states and union territories (UTs) free of cost. Of this, the total consumpti
-
Sputnik V Covid-19 vaccine: Dr Reddy’s expects first lot by May-end
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus
-
Legal action against Covishield maker in EU for delivery failure
AstraZeneca vaccine has been central to Europe's immunisation campaign, and a linchpin in the global strategy to get vaccines to poorer countries
-
Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin
Covaxin, along with Covishield manufactured by Serum Institute of India, are the two vaccines so far being used in India's current COVID-19 vaccinatio
-
Serum Institute of India defends Covid vaccine pricing, says initial rates based on advance funding
SII, which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 fo
-
Covid-19 vaccine: Centre’s flexible pricing policy will harm the public; earn producers super profits
By leaving the poor to the mercy of impecunious or uncaring state governments and profit-maximising private hospitals, the Centre has failed to live u
